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Background and purpose — Previous studies of patients who 
have undergone total hip arthroplasty (THA) due to femoral 
head necrosis (FHN) have shown an increased risk of revision 
compared to cases with primary osteoarthritis (POA), but recent 
studies have suggested that this procedure is not associated with 
poor outcome. We compared the risk of revision after operation 
with THA due to FHN or POA in 
the Nordic Arthroplasty Register Association (NARA) database 
including Denmark, Finland, Norway, and Sweden.
Patients and methods — 427,806 THAs performed between 
1995 and 2011 were included. The relative risk of revision for any 
reason, for aseptic loosening, dislocation, deep infection, and peri-
prosthetic fracture was studied before and after adjustment for 
covariates using Cox regression models. 
Results — 416,217 hips with POA (mean age 69 (SD 10), 59% 
females) and 11,589 with FHN (mean age 65 (SD 16), 58% females) 
were registered. The mean follow-up was 6.3 (SD 4.3) years. After 
2 years of observation, 1.7% in the POA group and 3.0% in the 
FHN group had been revised. The corresponding proportions 
after 16 years of observation were 4.2% and 6.1%, respectively. 
The 16-year survival in the 2 groups was 86% (95% CI: 86–86) 
and 77% (CI: 74–80). After adjusting for covariates, the relative 
risk (RR) of revision for any reason was higher in patients with 
FHN for both periods studied (up to 2 years: RR = 1.44, 95% 
CI: 1.34–1.54; p < 0.001; and 2–16 years: RR = 1.25, 1.14–1.38; 
p < 0.001).
Interpretation — Patients with FHN had an overall increased 
risk of revision. This increased risk persisted over the entire 
period of observation and covered more or less all of the 4 most 
common reasons for revision.  
 
Several studies of patients with femoral head necrosis (FHN) 
who have undergone total hip arthroplasty (THA) have shown 
an increased risk of revision compared to cases with primary 
osteoarthritis, but the literature in this field is not unanimous 
(Chandler et al. 1981, Cornell et al. 1985, Mont and Hunger-
ford 1995). We therefore estimated the risk of revision for 
patients with THA due to non-traumatic FHN and for patients 
with primary osteoarthritis (POA). To obtain a sufficiently 
large material, we used the Nordic Arthroplasty Register, 
which covers data from the Danish, Finnish, Norwegian, and 
Swedish national registries. 
Patients and methods
Sources of data
The Nordic Arthroplasty Register Association (NARA) was 
started in 2007 as a common database for Denmark, Norway, 
and Sweden. Finland joined the project in 2010. From 1995, all 
4 countries have used individual-based registration of opera-
tions and patients. The NARA database consists of data on hip 
replacements compiled from the 4 national joint replacement 
registries (Havelin et al. 2009). At the time of the analysis, 
the database included 536,418 operations performed between 
January 1, 1995 and December 31, 2011. 436,915 hips had 
been operated due to POA or FHN. All surface replacements 
and operations with missing information on any of the vari-
ables analyzed were excluded, leaving 427,806 cases with 
THA for the study.
There were 11,589 hips with FHN and 416,217 hips with 
POA. Follow-up started on the day of operation and ended on 
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the day of revision, death, or December 31, 2011. Revision 
was defined as removal or exchange of at least one of the pros-
thetic components. The average follow-up was 6.3 years (SD 
4.3) (range 0–17) in the POA group and 5.8 years (SD 4.2) 
(range 0–17) in the FHN group. 
Statistics
Kaplan-Meier survival analysis was used to estimate the unad-
justed cumulative revision rates. Data are presented as cumu-
lative survival (CS) with 95% confidence interval (CI). Cox 
multiple regression analysis was used to study the relative risk 
(RR) of revision, adjusting for age (5 groups: < 50, 50–59, 
60–69, 70–79, ≥ 80 years; or 2 groups: < 70 and ≥ 70), sex, 
and type of fixation. The proportional hazards assumption was 
evaluated with studies of survival curves and computation 
and plotting of Schoenfeld residuals. Analysis of fixation was 
separated into cemented or uncemented fixation of the cup and 
stem (1 variable each). The maximum follow-up was set at 16 
years. At this time, 3,402 patients in the FHN group (29%) and 
82,143 in the POA group (20%) had died. 
The risks of revision due to aseptic loosening, dislocation, 
deep infection, and periprosthetic fracture were studied sepa-
rately. Exploratory analyses revealed non-proportionality 
over time and high residuals in some of the analyses. Thus, 
the risk of revision for any reason was split into 2 periods, 
0–2 years and 2–16 years after the operation. Further sub-
grouping or group modification was done in the analyses 
of revision due to loosening, infection, and periprosthetic 
fracture due to time dependency of 1 or 2 of the variables 
age, sex, and stem fixation. To validate our calculations, they 
were repeated using 11,589 matched THAs in the group with 
POA for comparison. These operations were matched based 
on age, sex, and fixation of the cup and stem. The matching 
was performed by computation of propensity scores (nearest-
neighbor matching) (Rosenbaum and Rubin 1983). This vali-
dation gave essentially the same results (data not shown). All 
tests were 2-tailed and any p-value of < 0.05 was considered 
statistically significant. Statistical analyses were performed 
using SPSS software version 20.0 and the R statistics pack-
age.
Ethics
The study was approved by the Danish Data Protection Agency 
(J. no. 2008-41-2024), the Finnish National Committee for 
Medical Research Ethics (TUKIJA), and the Norwegian and 
the Swedish Data Inspection Boards.
Results
Demographics 
During the period of observation, the relative ratio of FHN 
to POA patients remained fairly constant, slightly below or 
above 3%. 58% of the THAs in patients with FHN were in 
females and 59% of the THAs in patients with POA were in 
females. 
Patients with FHN had a lower mean age (65 years (SD 
16)) than those operated due to POA (69 years (SD 10)) 
(p < 0.001). Overall, patients with FHN were more evenly 
distributed between the 5 age groups studied (< 50, 50–59, 
60–69, 70–79, ≥ 80 years) (Table 1).
Type of fixation
Patients with POA received cemented prostheses more fre-
quently (63%) than those with FHN (59%) (all-cemented; 
Table 1). The distribution regarding uncemented prostheses 
was reversed (23% and 26%). In the remaining groups of fixa-
tion, hips with FHN were more frequently represented (8.3% 
POA and 9.1% FHN, respectively, for hybrids and 5.0% POA 
and 5.9% FHN for reversed hybrids). Thus, uncemented cups 
and stems were used more frequently in hips with FHN (cups: 
32% and 35%; stems: 29% and 32%). 
Survival 
At 16 years, 6.9% of the hips had been revised in the group 
with FHN and 4.7% had been revised in the POA group. For 
all reasons for revision studied, the revision rate was higher in 
the study group (Table 1). After 2 years, the survival using all 
reasons for revision as outcome was lower in the FHN group 
than in the POA group (97% (95% CI: 96–97) and 98% (CI: 
98–98); p < 0.001). After 16 years, the survival had decreased 
Table 1. Patient demographics, type of fixation, and causes of revi-
sion
 
 FHN POA
  n, (%) n, (%)
Sex
 Male 4,868  (42)  168,847  (41) 
 Female 6,721  (58)  247,370  (59) 
Age 
 < 50 2,082  (18) 12,102  (2.9)
 50–59  2,022  (17) 54,750  (13)
 60–69 2,498  (22) 134,634  (32)
 70–79 2,863  (24) 156,987  (38)
 ≥ 80 2,124  (18) 57,744  (14)
Type of fixation
 Cup  
   Cemented 7,550  (65) 284,188  (68)
   Uncemented 4,039  (35) 132,029  (32)
 Stem  
   Cemented 7,931  (68) 297,673  (72)
   Uncemented 3,658  (32) 118,544  (29)
Causes of revision
 Any reason, 2 years 346  (3.0) 7,112  (1.7)
 Any reason, 16 years years 805  (6.9) 19,632  (4.7)
Specific reasons, 16 years  
 Loosening/lysis 317  (2.7) 9,603  (2.3)
 Dislocation 207  (1.8) 4,015  (1.0)
  Deep infection 121  (1.0) 2,627  (0.6)
  Periprosthetic fracture 74  (0.6) 1,249  (0.3)
  Other reasons 87  (0.8) 2,174  (0.5)
  Not revised 10,784  (93) 396,585  (95)
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to 77% (CI: 74–80) and 86% (CI: 86–86), respectively 
(p < 0.001). The 16-year survival was also lower in the FHN 
group when each of the outcomes loosening, infection, dis-
location, and periprosthetic fracture were studied separately 
(p < 0.001) (Figure). 
Separation of FHN patients who were operated 1995–2002 
and 2003–2011 revealed slightly lower 2-year survival for 
those operated during the later period (98% (CI: 97–98) 
vs. 96% (CI: 96–97); p = 0.002). After 8 years, the survival 
became more equal (92% (CI: 91–93) and 92% (CI: 90–93); 
p = 0.06). 
Risk of revision for any reason
A Cox regression model showed that the FHN group had 
more than twice the risk of having revision within 6 months 
compared to the POA group (adjusted RR = 2.2, CI: 1.9–2.6, 
detailed data not shown). At 2 years, the adjusted relative risk 
had decreased to 1.4 (CI: 1.3–1.5) (Table 2). From 2 to 16 
years, the unadjusted and adjusted risks decreased further, but 
were still higher in the FHN than in the POA group (adjusted 
RR = 1.3, CI: 1.1–1.4) (Table 2). Age-stratified analyses 
during the entire follow-up period (0–16 years) showed that 
the unadjusted and adjusted risk of revision was statistically 
significantly elevated for FHN patients compared to POA 
patients over 50 years of age, whereas in the youngest group 
(< 50 years) the risk was similar (p ≥ 0.09) (Table 3). 
Risk of revision for specific reasons
Before any adjustment, patients with FHN showed an increased 
risk of being revised due to loosening. Further analyses were 
done on data stratified for age and stem fixation, in order not 
to violate the proportional hazards assumption. Thus, in these 
analyses hips operated with cemented and cementless stems 
were studied separately. After adjusting for sex, age within 
each stratum, and cup fixation, we found increased risk of 
revision in the FHN group in patients who were 70 years and 
older in the group that was operated with a cemented stem 
(Table 4, see Supplementary data). Patients 70 years and older 
with FHN and operated with an uncemented stem also showed 
a higher risk, but this was not statistically significantly differ-
ent from that for those with primary OA. The number of hips 
in patients with FHN who were operated with an uncemented 
stem was, however, low (383 cases).
During the entire period of observation, the risk of revision 
due to dislocation was twice as high in the FHN group (Table 
5, see Supplementary data). Revision because of infection was 
stratified for age (< 70 and ≥ 70 years) due to non-proportion-
ality. After adjustment for covariates, the risk of being revised 
because of infection was increased in patients with FHN by 
about 70–80% depending on age (Table 6, see Supplementary 
data). 
Without any adjustment, patients with FHN had more than 
twice the risk of being revised due to periprosthetic frac-
Mean survival ± 95% CI according to 
Kaplan-Meier based on revision for any 
reason (panel A), loosening (B), dislocation 
(C), infection (D), and periprosthetic frac-
ture (E). Light gray: primary osteoarthritis; 
dark gray: femoral head necrosis.
 A  B
 D  E
 C
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ture compared to those operated due to POA. The risk ratio 
between males and females and between cemented and unce-
mented stems varied over time. The analyses were therefore 
stratified for sex and choice of stem fixation. Both males and 
females with FHN who were operated with a cemented stem 
showed an increased risk of being revised due to peripros-
thetic fracture. This increase in risk was particularly high in 
females. In patients operated with an uncemented stem, the 
situation was reversed. Males with FHN had more than twice 
the risk of that in males with POA, whereas in females the risk 
ratio was lower (Table 7, see Supplementary data).
Discussion 
Primary OA is the most common diagnosis for THA in stud-
ies from Europe, USA, and Australia, while FHN has been 
the most common diagnosis in several studies reported from 
Asia (Bouchain and Delorme 2003, Canadian Joint Replace-
ment Registry 2010, Lee et al. 2010, Australian Orthopedic 
Association National Joint Replacement Registry 2012). To 
our knowledge, there have been no reports focusing on the 
differences in the incidence of FHN worldwide. In a review 
article based on data collected until 1991, Mont and Hun-
gerford (1995) estimated that between 5% and 12% of the 
THAs in the USA were performed due to avascular necrosis. 
In a recent publication, Tofferi (2012) reported an incidence 
of about 10%, suggesting that this share has remained rather 
constant. In our study, the relative frequency was 2.2% of the 
total amount of THRs performed 1995–2011. Even though 
this figure is considerably lower, it did not change over the 
period of observation. 
Table 2. Relative risk of revision for any reason, from 0 to 2 years 
and after 2 years
Variable n RR 95% CI p-value
0–2 years    
Diagnosis unadjusted    
 FHN a 11,589 1.79 1.61–1.99 < 0.001
 Primary OA b  416,217 1 1 
Diagnosis adjusted    
 FHN a 11,589 1.44 1.34–1.54 < 0.001
 Primary OA b  416,217 1  
Age, years    
 < 50 14,184 0.73 0.64–0.82 < 0.001
 50–59  56,772 0.78 0.72–0.84 < 0.001
 60–69 137,132 0.82 0.78–0.87 < 0.001
 70–79 b 159,850 1  
 ≥ 80 59,868 1.08 1.005–1.16 0.04
Sex    
 Female b 254,091 1  
 Male 173,715 1.24 1.18–1.30 < 0.001
Cup    
 Cemented b 291,738 1  
 Uncemented 136,068 1.49 1.39–1.59 < 0.001
Stem    
 Cemented b  305,604 1  
 Uncemented 122,202 1.46 1.36–1.56 < 0.001
2–16 years    
Diagnosis unadjusted    
 FHN a 11,589 1.52 1.38–1.67 < 0.001
 Primary OA b  416,217 1 1 
Diagnosis adjusted    
 FHN a 11,589 1.25 1.14–1.38 < 0.001
 Primary OA b 416,217 1  
Age, years    
 < 50 14,184 2.37 2.19–2.56 < 0.001
 50–59  56,772 1.90 1.80–2.00 < 0.001
 60–69 137,132 1.53 1.47–1.60 < 0.001
 70–79 b 159,850 1  
 ≥ 80 59,868 0.60 0.54–0.65 < 0.001
Sex    
 Female b 254,091 1  
 Male 173,715 1.27 1.22–1.31 < 0.001
Cup    
 Cemented b 291,738 1  
 Uncemented 136,068 1.28 1.22–1.34 < 0.001
Stem    
 Cemented b  305,604 1  
 Uncemented 122,202 0.75 0.71–0.80 < 0.001
a
 FHN – Femoral head necrosis 
b
 Reference category
Table 3. Unadjusted and adjusted relative risk of revision in FHN 
and POA for any reason up to 2 years, separated into age groups. 
Adjustment for sex and for cup and stem fixation (risk ratios for 
covariates are not shown)
Age group/diagnosis n RR 95% CI p-value
Unadjusted    
 < 50 years    
  FHN a 2,082 1.13 0.97–1.31  0.1
  Primary OA b  12,108 1  
  50–59 years    
  FHN a 2,022 1.37 1.18–1.60 < 0.001
  Primary OA b  54,750 1  
 60–69 years    
  FHN a 2,498 1.79 1.55–2.06 < 0.001
  Primary OA b  134,634 1  
  70–79 years    
  FHN a 2,863 1.56 1.33–1.83 < 0.001
  Primary OA b  156,987 1  
 ≥ 80 years    
  FHN a 2,124 1.48 1.17–1.86 0.001
  Primary OA b  57,744 1  
Adjusted    
 < 50 years    
  FHN a 2,082 1.14 0.98–1.33  0.09
  Primary OA b  12,108 1  
 50–59 years    
  FHN a 2,022 1.36 1.17–1.59 < 0.001
  Primary OA b  54,750 1  
 60–69 years    
  FHN a 2,498 1.84 1.60–2.12 < 0.001
  Primary OA b  134,634 1  
 70–79 years    
  FHN a 2,863 1.69 1.44–1.98 < 0.001
  Primary OA b  156,987 1  
 ≥ 80 years    
  FHN a 2,124 1.63 1.29–2.05 < 0.001
  Primary OA b  57,744 1
  
a
 FHN – Femoral head necrosis 
b
 Reference category
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Early clinical studies of THA inserted in cases with FHN 
reported high failure rates (Chandler et al. 1981, Cornell et al. 
1985, Mont and Hungerford 1995). More recent studies have, 
however, found that the revision rate in patients with FHN is 
comparable to those reported in cases with POA (Piston et 
al. 1994, Wei et al. 1999 Fyda et al. 2002, Hungerford et al. 
2006, Conroy et al. 2008, Bose and Baruah 2010, Kim et al. 
2010, Johannson et al. 2011). Wei et al. (1999) concluded 
that patients with FHN could expect results similar to those 
observed in patients with primary OA, even after revision 
surgery. Idiopathic FHN is a rare diagnosis and many of the 
studies performed have been small and retrospective (Table 
8, see Supplementary data). In the present study, the risk of 
early revision was slightly higher in the patient group with 
FHN during the late period (2003–2011), but this difference 
appeared to level out with time. This observation contradicts 
the results of Johannson et al. (2011). These authors did, how-
ever, separate their patients into those operated before 1990 
and those operated during 1990 and later, which could be one 
explanation. 
Previous registry studies have shown inconsistent results 
regarding the risk of revision after operation with THA in these 
patients. In the Norwegian Arthroplasty Register, Furnes et al. 
(2001) did not find an increased risk of revision based on 415 
cases compared to 37,215 THAs operated because of POA. 
Conroy et al. (2008) evaluated data from the Australian Reg-
ister and found an increased risk of revision due to dislocation 
in these cases. In a literature review including 3,277 THAs in 
2,593 patients, Johannson et al. (2011) found that the revision 
rate was lower in patients operated after 1990. It was higher 
in patients with FHN associated with sickle cell disease, Gau-
cher disease, or renal failure, but these high-risk groups only 
constituted less than 20% of the cases. Johnsen et al. (2006) 
studied 1,093 THA patients in the Danish Hip Arthroplasty 
Register who were operated between 1995 and 2001 because 
of FHN. They observed an increased risk of revision during 
the postoperative month, but no difference compared to POA 
6 months to 9 years after the index operation. In general, the 
reason for revision varies over time (Garellick et al 2009). 
During the first 2 years, dislocation and infection are the most 
common causes whereas revisions due to loosening or lysis 
will peak later on. Thus, these discrepancies between studies 
could be related to variable time to follow-up—and also to 
skewed implant selection and insufficient numbers included.
A limitation of most registry-based studies is that only 
a revision operation is considered as a definition of failure. 
Some patients with poor clinical results may not be revised, 
and some with radiographic failure have minor or no clini-
cal symptoms or may not be revised due to poor general 
health. In this respect, however, younger patients are probably 
revised earlier than elderly patients. This might have skewed 
the results in the present study since patients with FHN were 
somewhat younger than those with primary OA. The Nordic 
registries have complete coverage, which means that all hos-
pitals participate. The completeness of data on primary proce-
dures varies between 86% and 99% in the 4 countries. Revi-
sions are probably under-reported to a certain extent, but there 
is no reason to believe that any such under-reporting should 
differ between the 2 patient groups studied. However, it is pos-
sible that centers with more experience performed the major-
ity of the replacements in the young patients and thereby more 
of the patients with FHN, which could have been a possible 
source of bias. 
We found that the risk of revision in FHN patients for any 
reason was more than double during the first 6 postoperative 
months. After 2 years, it decreased to about 50%. Compared 
to the group with POA, revisions due to dislocation, infection, 
and periprosthetic fracture were especially common. These 
causes—and particularly dislocation and infection—often 
result in early revisions. Revision due to periprosthetic frac-
tures may also occur early, and especially with use of unce-
mented stems. High age was a risk factor for early revision, 
whereas revisions after 2 years were more common in younger 
patients. The reason may be that older patients more often 
suffer from dislocation and infection whereas loosening is a 
more important problem in the younger population.
Previous studies have found that men have a higher risk of 
being revised for any reason than women (Fukushima et al. 
2010, Katz et al. 2012). This is in accordance with our findings. 
Further studies of the 4 most common reasons for revision 
revealed that there was poorer outcome for males concerning 
loosening, infection, and periprosthetic fracture, whereas the 
risk of revision due to dislocation was about the same. 
FHN has been associated with risk factors and/or diseases 
that, in different ways, may influence the outcome of a THR. 
Some of the most common risk factors or diseases are exces-
sive alcohol consumption, smoking, heart/kidney transplanta-
tion, corticosteroids, and systemic lupus erythematosus (Brad-
bury et al. 1994, Mont and Hungerford 1995, Lieberman et al. 
2000, Mahoney et al. 2005, Mont et al. 2006). These condi-
tions or their treatment will frequently result in inferior bone 
quality and reduced resistance to infections. Mental confusion 
in association with various types of abuse might also influence 
the risk of dislocation, infection, and periprosthetic fracture. 
Another contributory factor for increased risk of revision in 
patients with FHN may be that osteonecrosis tends to affect 
younger individuals. FHN predominated in the age group 
below 50 years, with a group mean of about 65 years. Accord-
ing to the age-stratified analyses, there was an increase in risk 
for all age groups except the one below 50 years of age. This 
rather speaks against the idea that age should have a decisive 
influence on the increased revision rate in cases with this diag-
nosis. Patients with primary OA were generally older, which is 
in line with previously reported data (Johannson et al. 2011).
Younger people have higher activity than older patients, 
placing more stress on the implant. On the other hand, the 
increase in risk of revision because of loosening in patients 
with FHN was not as pronounced as for the other 3 causes 
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studied. After adjustment for covariates, a statistically signifi-
cant increase could only be established for patients over 70 
years of age who were operated with a cemented stem. Also, 
in the group operated with an uncemented stem the risk ratio 
was higher—but not statistically significantly so. However, 
uncemented stems were rarely used in these cases, resulting 
in few observations. These findings suggest that any influence 
of FHN (or its causes) on the quality of the bone—with the 
potential to influence the risk of loosening—is only relevant 
in older patients. 
Compared to patients with POA, we found that an increased 
risk of revision was associated with the presence of FHN in 
patients who were 50 years of age or more. The risk ratio 
increased up to 60–69 years, and tended to decrease thereaf-
ter. The reason for this age dependence is not clear. It could 
be related to our observation that the influence of FHN on the 
risk of revision varies between causes of revision. Disloca-
tion, infection, and periprosthetic fracture had the highest risk 
ratios. These complications are common in the early period 
after a THA and are more common in elderly patients. With 
time, loosening will become more and more a cause of revi-
sion; we only (and after adjustment for covariates) found a dif-
ference between the diagnoses in patients 70 years and older 
who were operated with a cemented stem. 
FHN increases the risk of a future revision in a complex 
way. It could be that bone necrosis results in secondary 
changes in the quality of the bone and soft tissues around the 
hip, which contributes to these complications. It does seem 
more probable that metabolic changes or other factors preced-
ing the development of necrosis are responsible. To explore 
these issues, further cross-matching with healthcare and phar-
maceutical registers would be of interest. 
In summary, patients with FHN have a higher risk of being 
revised than those operated due to POA—and especially up to 
2 years after the primary operation. Over the entire observa-
tion period of 16 years, the most pronounced differences were 
observed for the causes periprosthetic fracture, dislocation, 
and infection. 
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